apl. Prof. Dr. Sabine Semrau

Medizinische Fakultät

Deep learning for automatic head and neck lymph node level delineation provides expert-level accuracy (2023) Weissmann T, Huang Y, Fischer S, Roesch J, Mansoorian S, Gaona HA, Gostian AO, et al. Journal article, Original article Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (TEMRA) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial (2023) Scheer I, Becker I, Schmitter C, Semrau S, Fietkau R, Gaipl U, Frey B, Donaubauer AJ Journal article Positive factors on survival of head and neck cancer of unknown primary: what the clinician can do (2023) Khalil F, Koch M, Iro H, Sievert M, Haderlein M, Semrau S, Fietkau R, et al. Journal article Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control (2023) Willner A, Agaimy A, Fechner K, Ott O, Denz A, Weissmann T, Meidenbauer N, et al. Journal article Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution, Abstract of a poster Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP) (2022) Balk M, Rupp R, Mantsopoulos K, Allner M, Grundtner P, Müller SK, Traxdorf M, et al. Conference contribution Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer (2022) Beck M, Semrau S, Haderlein M, Gostian AO, Hartwich J, Müller SK, Kallies A, et al. Journal article Is elective irradiation of lymph node levels IV and Vb necessary in nasopharyngeal carcinoma? (2022) Semrau S, Haderlein M Journal article, Editorial Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial. (2022) Hecht M, Eckstein M, Kallies A, Klautke G, Illmer T, von der Grün J, Laban S, et al. Conference contribution Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma (2022) Kohl V, Weber K, Brunner M, Geppert CI, Fietkau R, Grützmann R, Semrau S, Merkel S Journal article